Roche Holding AG
SIX:ROG
Roche Holding AG
Cash from Operating Activities
Roche Holding AG
Cash from Operating Activities Peer Comparison
Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Roche Holding AG
SIX:ROG
|
Cash from Operating Activities
CHf16.1B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
0%
|
|
Novartis AG
SIX:NOVN
|
Cash from Operating Activities
$14.5B
|
CAGR 3-Years
2%
|
CAGR 5-Years
0%
|
CAGR 10-Years
1%
|
|
NLS Pharmaceutics AG
NASDAQ:NLSP
|
Cash from Operating Activities
-$13.9m
|
CAGR 3-Years
-318%
|
CAGR 5-Years
-21%
|
CAGR 10-Years
N/A
|
|
S
|
Sandoz Group AG
SIX:SDZ
|
Cash from Operating Activities
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Roche Holding AG's Cash from Operating Activities?
Cash from Operating Activities
16.1B
CHF
Based on the financial report for Dec 31, 2023, Roche Holding AG's Cash from Operating Activities amounts to 16.1B CHF.
What is Roche Holding AG's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 10Y
0%
Over the last year, the Cash from Operating Activities growth was -10%. The average annual Cash from Operating Activities growth rates for Roche Holding AG have been -5% over the past three years , -4% over the past five years .